Welcome to the Library, where you'll find a selection of industry resources including eBooks, Whitepapers, Webinars, Survey Reports, Research Reports and more.
If you are interested in submitting items to the Library, please contact our advertising team
LIBRARY
The Basics of Biotech 101, 201 & 301
This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. This series provides an overview of the science and technology used to enable discovery and the processes scientists use to discover new therapeutics. Download now.
Pharmaceutical Development for ADCs: Not as Simple as ABC
Formulation, process, and analytical development for ADCs is complex. Join our experts as we discuss ADC structure and function, the development process (including analytical methods, stability, and lyo cyle optimization) and parenteral product development. Register Today!
Mobile HTML5 For The Enterprise: The Optimum Path to Seamless and Secure Enterprise Mobility
The key factors when choosing HTML5 as the development platform for mobile. Download Now.
Single Use Technology: From Bioprocess Convenience to Drug-Development Driver
In order to accelerate the production of biological molecules, companies have been exploring disposable, single-use systems. Download this ebook to learn the impact and future use of single-use technologies, cost-saving opportunities, and challenges of implementing new drug development processes.
IT challenges for the mobile health market
The mobile health market is moving rapidly, with apps now helping patients collect health data and physicians tapping into that data remotely. Join as we examine mobile health advances, patient privacy challenges, and how the FDA is evolving its thinking on regulating mobile apps. Register Today!
Modernizing Pharmaceutical R&D with Metabolomics - Reducing Attrition with Better Models, Compounds, and Biomarkers
This webinar will convey the utility of metabolomics for developing or determining the most appropriate animal model for target/compound evaluation, providing a high-resolution assessment of compounds to add assurance and guidance in candidate selection, and elucidating sensitive and specific biomarkers of disease and response. Register today to tune into this live event.
Clinical trials in Asia: Opening up to the world
The number of clinical trials carried out in Asia is rising. While talking about 'Asia' as a whole can be a bit of a generalization, the region has a number of advantantages for companies moving into clinical trials. This webinar will discuss quality assurance in overseas clinical trials and how to handle the regulatory maze. Watch Now.
Pay HCPs...NOT Penalties
Watermark's Shade Solution: pay HCP, tracking, reporting, and managing yearend tax forms, and int'l. Find out more and download today!
Opportunities and Challenges in Emerging Markets
Join as we discuss the commercial opportunities in emerging markets and the rise of the pharmaceutical industry in China and other countries. Importantly, learn what regulatory and reimbursement challenges present potential hurdles to succeeding in emerging markets. Watch Now!
The Boom in Rare-Disease Drug R&D
Big Pharma and a growing number of up-and-coming biotechs alike have focused their attention on developing new drugs for rare diseases. Join a panel of experts to discuss R&D strategies, patient communications and recruitment, and new regulatory changes which promise to shorten development timelines. Watch Now!
Conversations with World-Class Biotech Innovators
What elevates a researcher to the top of the industry? FierceBiotech profiled five prominent researchers and asked them how they garnered such success. Download for free today.
Drugmakers go mobile
With a steady stream of new mobile apps, pharma companies aim to catch up with their target audiences on a number of fronts. But what makes a winning mobile app in pharma? Join as we discuss how drugmakers have effectively raised their mobile games to achieve a variety of strategic objectives. Watch Now!
Facing Up to the Biosimilar Challenge: Preclinical and Beyond
Faced with a continuing economic crisis and an aging and increasingly obese population, healthcare providers are seeing where they can cut costs. Generics saved the U.S. healthcare system $192 billion in 2011 alone. To read more on this timely topic, download this eBook today.
Special Report: China's Rise Drives Investment in Biotech Drugs
The Chinese government's devotion to biotech has sparked major expansion efforts by some of the country's leading pharmaceutical players, also making it fertile ground for venture capitalists in the U.S. Click here to download the complete report today.
Orphan Drug Differentiation
Join as we hear experts from orphan drug units explain how the commercial landscape of their field is changing and how orphan drug specialists have optimized patient access. Glean the latest insights on working with payers and reimbursement and get the pulse on the market and how competition brought key changes. Watch Today!
Discover Causal Connections. Faster.
The formation, maintenance and repair of epithelial barriers are of critical importance for whole body homeostasis. However the deregulation of these pathways gives rise to disease states such as fibrosis and carcinogenesis. Join us as we discuss Ingenuity's IPA, its newest features and how it is being used in research today. Register Today!
Bioavailability Challenges
In recent years, researchers and companies have faced increasing challenges in the discovery and development of new drugs. The challenge for Pharma companies has become maximizing the bioavailability of molecules that demonstrate activity, but are often poorly soluble and/or permeable, by selection and careful utilization of the right drug delivery technologies. Click here to download this eBook today.
FierceBiotech Special Report: Armed Antibodies Readied for War on Cancer
For the drug developers looking to bring these products to market, ADCs represent the inevitable marriage of two sometimes hit-or-miss technologies, chemotherapy and antibodies, the next generation of anti-cancer compounds. In this Special Report FierceBiotech explores the potential and the challenges of the burgeoning field of ADCs.
